Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations
As healthcare costs continue to rise, accurate cost-effectiveness estimates are crucial. However, estimating the costs and outcomes of different interventions is complicated by uncertainty.
In model-based health economic evaluations (HEEs), uncertainty can arise from limited data, methodological limitations, and variability in clinical outcomes.
A recent review identified 80 methods for identifying, analyzing, and communicating uncertainty in HEEs. Quantifying uncertainty wherever possible is crucial to ensure accurate and unbiased cost-effectiveness estimates, ultimately leading to optimal allocation of healthcare resources
Recent Posts
Genotype ECG Prediction
Bridging Genotype ECG Prediction to Enhanced Cardiovascular Risk Assessment
Genotype ECG prediction advancements, exemplified by the CapECG model, enable direct mapping of genetic data to electrocardiogram ...
Glofitamab Cost-Effectiveness: Conditional Reimbursement Insights for DLBCL Treatment
Glofitamab Cost-Effectiveness in R/R DLBCL Reimbursement
Glofitamab cost-effectiveness analysis by Zorginstituut Nederland supports conditional inclusion of glofitamab (Columvi®) with gemcitabine and oxaliplatin (Glofit-GemOx)...
NICE Endorses Pegzilarginase for Treating Arginase Deficiency
NICE Backs Pegzilarginase for Arginase Deficiency
The National Institute for Health and Care Excellence (NICE) final draft guidance recommends pegzilarginase arginase deficiency treatment (Loargys, Immedica) as an option for people ...